Physician profile
Thomas T Lee
NPI 1770660797
$2,412.57
in general payments reported to CMS, 2019-2025
17 companies · $41.19 in 2025
The $41.19 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $404 · 2021: $590 · 2022: $446 · 2023: $355 · 2024: $27.78 · 2025: $41.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $531.28 | 2020-2023 | Reline |
| Djo, LLC | $219.56 | 2019-2025 | Cmf |
| Medtronic USA, INC. | $176.46 | 2019-2020 | |
| Orthofix Medical, INC. | $175.44 | 2020-2023 | Spinal-Stim, Spinal-Stim |
| Nevro Corp. | $175.09 | 2019-2022 | |
| Medtronic, INC. | $174.66 | 2021-2022 | |
| Abbott Laboratories | $165.52 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $144.50 | 2022 | |
| Si-Bone, INC. | $140.54 | 2021-2022 | |
| Zimvie INC. | $105.34 | 2023 | |
| Relievant Medsystems, INC. | $103.26 | 2021 | |
| Allergan, INC. | $97.33 | 2019 | |
| Stryker Corporation | $70.33 | 2019 | |
| Boston Scientific Corporation | $67.03 | 2019-2021 | |
| Lilly USA, LLC | $27.78 | 2024 | Amyvid |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $20.38 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.